Literature DB >> 4026268

In vitro activity of cefbuperazone and other antimicrobial agents against isolates from the female genital tract.

M J Ohm-Smith, R L Sweet, W K Hadley.   

Abstract

Cefbuperazone (BMY 25182), a new cephamycin, showed activity similar to those of moxalactam and other cephalosporin-cephamycins against aerobic and anaerobic bacteria from female genital tract infections. MICs of the antimicrobial agents were less than or equal to 16 micrograms/ml for greater than 97% of organisms tested. All of the anaerobic bacteria tested were susceptible to clindamycin, metronidazole, and chloramphenicol.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4026268      PMCID： PMC180195          DOI： 10.1128/AAC.27.6.958

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.

Authors:  M Tai; Y Fukuoka; A Yotsuji; K Kumano; M Takahata; H Mikami; T Yasuda; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

2.  Cefotaxime sodium therapy for endomyometritis following cesarean section: dose-finding and comparative studies.

Authors:  D L Hemsell; F G Cunningham; R T DePalma; B J Nobles; M Heard; P G Hemsell
Journal:  Obstet Gynecol       Date:  1983-10       Impact factor: 7.661

3.  Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.

Authors:  R L Sweet; W J Ledger
Journal:  Obstet Gynecol       Date:  1979-08       Impact factor: 7.661

4.  Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections.

Authors:  R L Sweet; M O Robbie; M Ohm-Smith; W K Hadley
Journal:  Am J Obstet Gynecol       Date:  1983-02-01       Impact factor: 8.661

5.  In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections.

Authors:  M J Ohm-Smith; W K Hadley; R L Sweet
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

6.  Moxalactam for obstetric and gynecologic infections. In vitro and dose-finding studies.

Authors:  F G Cunningham; D L Hemsell; R T DePalma; S Kappus; M Roark; B Nobles
Journal:  Am J Obstet Gynecol       Date:  1981-04-15       Impact factor: 8.661
  6 in total
  2 in total

1.  Tetracycline resistance in Peptostreptococcus species.

Authors:  M C Roberts
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

2.  In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.

Authors:  M J Ohm-Smith; R L Sweet
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.